+44 (0) 1865 606333 enquiries@visibleanalytics.co.uk

Virtual ISPOR Europe 2020
16-19 November

We are looking forward to sharing Visible Analytics and our colleagues’ latest research.

Check out our work and do not hesitate to get in touch.

Issue Panel

IP-15 Is Intention-to-Treat Analysis Still the Gold Standard, or Should All HTA Authorities and Regulators Now Embrace the ICH E(9)R(1) Addendum on Estimands and Sensitivity Analyses?

with Prof. Neil Hawkins MSc, MBA, PhD, CStat

Thursday, 19 November 2020.
14:30 – 15:30 Breakout Session 5

Workshop

W1: Carer Utilities in Cost-Utility Analyses: Crucial Information or Additional Burden of Uncertainty?

with Noemi Muszbek, MSc and Edit Remak, PhD

Tuesday, 17 November 2020
17:00 – 18:00 Breakout Session 2

Download

Poster presentations

PCN65: Economic Impact of First-Line (1L) Immunotherapies in Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR).

Sarri G, Freitag A, Kazmierska P1, Lin B, Pawar V, Zhang X.

Available to registered conference attendees in ISPOR Europe 2020 Virtual Poster Gallery

PCN69: Modeling Approaches in Cost-Effectiveness Analysis (CEA) of First-Line (1L) Immuno-Oncology (IO) Therapies in Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR).

Kongnakorn T, Walker A, Sarri G, Freitag A, Marczell K, Kazmierska P, Masters E, Pawar V, Zhang X.

Available to registered conference attendees in ISPOR Europe 2020 Virtual Poster Gallery